# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-003998
Filing Date
2022-03-17
Accepted
2022-03-17 06:31:28
Documents
105
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | ikna-20211231.htm iXBRL | 10-K | 2951276
2 | EX-4.3 | ikna-ex4_3.htm | EX-4.3 | 54229
3 | EX-23.1 | ikna-ex23_1.htm | EX-23.1 | 6740
4 | EX-31.1 | ikna-ex31_1.htm | EX-31.1 | 15762
5 | EX-31.2 | ikna-ex31_2.htm | EX-31.2 | 15635
6 | EX-32.1 | ikna-ex32_1.htm | EX-32.1 | 19089
7 | GRAPHIC | img39825204_0.jpg | GRAPHIC | 53981
8 | GRAPHIC | img39825204_1.jpg | GRAPHIC | 24159
9 | GRAPHIC | img39825204_2.jpg | GRAPHIC | 86334
10 | GRAPHIC | img39825204_3.jpg | GRAPHIC | 43163
11 | GRAPHIC | img39825204_4.jpg | GRAPHIC | 21792
12 | GRAPHIC | img39825204_5.jpg | GRAPHIC | 25020
13 | GRAPHIC | img39825204_6.jpg | GRAPHIC | 29065
14 | GRAPHIC | img39825204_7.jpg | GRAPHIC | 25609
15 | GRAPHIC | img39825204_8.jpg | GRAPHIC | 116456
16 | GRAPHIC | img39825204_9.jpg | GRAPHIC | 277518
17 | GRAPHIC | img39825204_10.jpg | GRAPHIC | 46202
18 | GRAPHIC | img39825204_11.jpg | GRAPHIC | 35884
19 | GRAPHIC | img39825204_12.jpg | GRAPHIC | 25898
20 | GRAPHIC | img39825204_13.jpg | GRAPHIC | 56954
21 | GRAPHIC | img39825204_14.jpg | GRAPHIC | 42271
22 | GRAPHIC | img39825204_15.jpg | GRAPHIC | 96313
23 | GRAPHIC | img39825204_16.jpg | GRAPHIC | 42134
24 | GRAPHIC | img39825204_17.jpg | GRAPHIC | 65556
25 | GRAPHIC | img39825204_18.jpg | GRAPHIC | 130451
26 | GRAPHIC | img39825204_19.jpg | GRAPHIC | 59134
27 | GRAPHIC | img39825204_20.jpg | GRAPHIC | 69573
28 | GRAPHIC | img39825204_21.jpg | GRAPHIC | 65921
29 | GRAPHIC | img39825204_22.jpg | GRAPHIC | 124310
30 | GRAPHIC | img39825204_23.jpg | GRAPHIC | 92296
| Complete submission text file | 0000950170-22-003998.txt |  | 12985115

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
31 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ikna-20211231.xsd | EX-101.SCH | 57561
32 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ikna-20211231_pre.xml | EX-101.PRE | 343885
33 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ikna-20211231_def.xml | EX-101.DEF | 169367
34 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | ikna-20211231_cal.xml | EX-101.CAL | 50523
35 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ikna-20211231_lab.xml | EX-101.LAB | 472228
99 | EXTRACTED XBRL INSTANCE DOCUMENT | ikna-20211231_htm.xml | XML | 1370586

Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40287 | Film No.: 22746669
SIC: 2836 Biological Products, (No Diagnostic Substances)